Breaking News Instant updates and real-time market news.

EADSY

Airbus

$0.00

(0.00%)

, BDRBF

Bombardier

$0.00

(0.00%)

06:27
07/10/18
07/10
06:27
07/10/18
06:27

Airbus sees double-digit CSeries orders this year, Reuters reports

Airbus (EADSY) expects to sell a double-digit number of CSeries jets this year and estimates demand for at least 3,000 of the aircraft over the next 20 years, Reuters reports, citing CSeries sales chief David Dufrenois. Airbus, which sees demand for 6,000-7,000 aircraft in the 100-150 sear category over 20 years, is set to unveil a new brand for the CSeries after completing its purchase of the struggling jet program from Bombardier (BDRBF) on July 1. Reference Link

EADSY

Airbus

$0.00

(0.00%)

BDRBF

Bombardier

$0.00

(0.00%)

  • 10

    Jul

  • 02

    Aug

EADSY Airbus
$0.00

(0.00%)

05/09/18
BERN
05/09/18
NO CHANGE
BERN
U.S. exiting Iran deal minor negative for Boeing, Airbus, says Bernstein
Bernstein analyst Douglas Harned notes that President Trump announced that the U.S. will withdraw from the 2015 Iran nuclear accord, and will reinstate sanctions on that country. The analyst sees only minimal impact to commercial aerospace as neither Airbus (EADSY) nor Boeing (BA) will change production rates on this change, and the total number of orders affected represents just 2% of the companies' combined order backlogs. For defense contractors with significant Middle Eastern exposure, heightened regional tensions could drive increased demand for missile defense, in particular, but potentially also aircraft, ships, missiles, and vehicles, he contends. Harned believes Raytheon (RTN) is well positioned, having the highest exposure to missile defense and tactical missile sales to the Middle East, with Lockheed Martin (LMT) also a strong player.
05/17/18
BERN
05/17/18
NO CHANGE
Target $422
BERN
Outperform
WTO rulings 'clearly in favor' of Boeing, says Bernstein
Bernstein analyst Douglas Harned commented on the WTO Appellate Body ruling on A350 and A380 launch aid. In a research note to investors, Harned contented that many findings went in Airbus' (EADSY) direction, he views the most important issues as A350 and A380 launch aid and that issues on earlier subsidies are "not considered relevant." The rulings on A350 and A380 launch aid, he said, appear to be "clearly in favor" of Boeing (BA), but added that it is unclear what scale of action is now warranted in response. He expects the AB's action related to EU claims of Boeing subsidies to come later this year. The analyst has an Outperform rating on Airbus and Boeing, with respective targets of EUR129 and $422.
06/15/18
BERN
06/15/18
NO CHANGE
Target $422
BERN
Outperform
Etihad fleet plan changes shouldn't be major issue for Boeing, says Bernstein
After The Wall Street Journal reported that Etihad Airways may seek to defer or cancel its 25 orders for Boeing (BA) 777Xs as part of a broad restructuring program, Bernstein analyst Douglas Harned said he expects the direct financial impact to be minimal as Boeing should be able to resell the slots for the five 777Xs expected to be delivered before 2022 and Etihad would have to pay penalties. While risk to the 777X program is a broader and more important concern, Harned noted that Boeing's CEO expressed confidence in 777X demand at Bernstein's conference just two weeks ago and the analyst sees very little long-term risk to this program. He keeps an Outperform rating and $422 price target on Boeing.
06/22/18
JPMS
06/22/18
NO CHANGE
JPMS
Overweight
JPMorgan adds Airbus added to Analyst Focus List, removes Safran
JPMorgan analyst David Perry added Airbus (EADSY) to his firm's Analyst Focus List and raised his price target for the shares to EUR 133 from EUR 122. The analyst removed Safran (SAFRY) from the Focus List. Perry keeps Overweight ratings on both stocks. He remains "very positive" on Safran but sees more upside in Airbus.
BDRBF Bombardier
$0.00

(0.00%)

11/21/17
JPMS
11/21/17
UPGRADE
JPMS
Overweight
Bombardier upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Seth Seifman upgraded Bombardier to Overweight citing increased confidence in the company's turnaround and potential for upside over the next 12-18 months if it can bring the Global 7000 into service successfully.
02/20/18
COWN
02/20/18
UPGRADE
COWN
Outperform
Bombardier upgraded to Outperform from Market Perform at Cowen
Cowen analyst Cai von Rumohr upgraded Bombardier to Outperform from Neutral citing its leveraged turnaround with improving execution, firming business jet demand, and receding Global 7000/"C" series risks.
03/29/18
LEHM
03/29/18
INITIATION
LEHM
Overweight
Bombardier initiated with an Overweight at Barclays
Barclays analyst David Strauss started Bombardier (BDRBF) with an Overweight rating and C$5 price target. The analyst believes expectations for U.S. Aerospace & Defense are too low and initiated the sector with a Positive rating. Fundamentals look poised to deliver accelerating growth against consensus, the analyst contends. He favors TransDigm Group (TDG) in Aerospace and his top pick overall is L3 Technologies (LLL).
03/29/18
03/29/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boeing (BA), Allegheny Technologies (ATI), Textron (TXT), Spirit AeroSystems (SPR), Northrop Grumman (NOC), Bombardier (BDRBF), Huntington Ingalls (HII), L3 (LLL) and General Dynamics (GD) were initiated with an Overweight at Barclays, while Arconic (ARNC), Harris (HRS), Lockheed Martin (LMT), Triumph Group (TGI), Raytheon (RTN) and Hexcel (HXL) initiated with an Equal Weight and Esterline (ESL) and BWX Technologies (BWXT) were initiated wtih an Underweight. 2. Spotify (SPOT) initiated with an Outperform at RBC Capital. 3. International Paper (IP) initiated with a Buy at UBS. 4. American Homes 4 Rent (AMH) and Invitation Homes (INVH) initiated with an Outperform at Baird. 5. Pilgrim's Pride (PPC) initiated with a Buy at Mizuho. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

TTWO

Take-Two

$118.82

-1.69 (-1.40%)

14:30
10/23/18
10/23
14:30
10/23/18
14:30
Periodicals
'Red Dead Redemption 2' development a difficult experience, Kotaku says »

Take-Two's Rockstar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

, HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

14:29
10/23/18
10/23
14:29
10/23/18
14:29
Recommendations
Selecta Biosciences, Horizon Pharma analyst commentary  »

Selecta SEL-212 data…

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

BCS

Barclays

$8.60

0.11 (1.30%)

14:20
10/23/18
10/23
14:20
10/23/18
14:20
Options
8-strike put buyers in Barclays Bank ahead of earnings »

8-strike put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SELB

Selecta Biosciences

$8.93

-4.44 (-33.21%)

14:19
10/23/18
10/23
14:19
10/23/18
14:19
Recommendations
Selecta Biosciences analyst commentary  »

Selecta Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SLG

SL Green Realty

$92.15

0.36 (0.39%)

14:18
10/23/18
10/23
14:18
10/23/18
14:18
Downgrade
SL Green Realty rating change  »

SL Green Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/23/18
10/23
14:17
10/23/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$133.39

-7.945 (-5.62%)

14:16
10/23/18
10/23
14:16
10/23/18
14:16
Recommendations
Centene analyst commentary  »

Centene should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 14

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/23/18
10/23
14:16
10/23/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$22.65

-1.255 (-5.25%)

14:15
10/23/18
10/23
14:15
10/23/18
14:15
Options
KKR put volume heavy and directionally bearish »

Bearish flow noted in KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

SBH

Sally Beauty

$17.78

0.28 (1.60%)

14:09
10/23/18
10/23
14:09
10/23/18
14:09
Hot Stocks
Sally Beauty unveils Sally Beauty Rewards »

"Sally Beauty …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAD

iCAD

$3.10

-0.02 (-0.64%)

14:06
10/23/18
10/23
14:06
10/23/18
14:06
Hot Stocks
iCAD announces new clinical data on the Xoft Electronic Brachytherapy System »

iCAD announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

AMD

AMD

$24.73

-0.31 (-1.24%)

14:05
10/23/18
10/23
14:05
10/23/18
14:05
Hot Stocks
AMD, Oracle collaborate on EPYC processor-based offering »

At Oracle's (ORCL)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Dec

UNH

UnitedHealth

$261.89

-0.26 (-0.10%)

14:05
10/23/18
10/23
14:05
10/23/18
14:05
Options
UnitedHealth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$152.62

-2.19 (-1.41%)

14:03
10/23/18
10/23
14:03
10/23/18
14:03
Hot Stocks
Facebook introduces Messenger 4 »

In a blog posting,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

14:00
10/23/18
10/23
14:00
10/23/18
14:00
General news
Breaking General news story  »

Dallas Federal Reserve…

KR

Kroger

$28.16

0.17 (0.61%)

13:58
10/23/18
10/23
13:58
10/23/18
13:58
Hot Stocks
Kroger hiring 10,000 associates for holiday season »

The Kroger Co. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

EXAS

Exact Sciences

$63.00

0.68 (1.09%)

13:55
10/23/18
10/23
13:55
10/23/18
13:55
Periodicals
Exact Sciences named a core healthcare short at Hedgeye »

Hedgeye named Exact…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

EOG

EOG Resources

$110.23

-6.03 (-5.19%)

13:55
10/23/18
10/23
13:55
10/23/18
13:55
Options
EOG Resources put volume heavy and directionally bearish »

Bearish flow noted in EOG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

SELB

Selecta Biosciences

$9.06

-4.31 (-32.24%)

, HZNP

Horizon Pharma

$18.52

-0.735 (-3.82%)

13:53
10/23/18
10/23
13:53
10/23/18
13:53
Hot Stocks
Street Fight: Analysts diverge on Selecta Bio's gout drug data read-through »

Shares of Selecta…

SELB

Selecta Biosciences

$9.06

-4.31 (-32.24%)

HZNP

Horizon Pharma

$18.52

-0.735 (-3.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

13:50
10/23/18
10/23
13:50
10/23/18
13:50
General news
Fed's Bostic continues to tout a gradual path of tightening »

Fed's Bostic…

UNP

Union Pacific

$143.76

-3.04 (-2.07%)

13:47
10/23/18
10/23
13:47
10/23/18
13:47
Periodicals
Union Pacific eliminating 475 positions by year end, World-Herald says »

Union Pacific said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

LNG

Cheniere Energy

$61.13

-2.36 (-3.72%)

13:45
10/23/18
10/23
13:45
10/23/18
13:45
Options
Cheniere Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

GOOG

Alphabet

$1,095.61

-4.91 (-0.45%)

, GOOGL

Alphabet Class A

$1,104.31

-6.89 (-0.62%)

13:44
10/23/18
10/23
13:44
10/23/18
13:44
Periodicals
Google will fix Pixel photo saving issue with software update, Verge says »

Google will fix a trouble…

GOOG

Alphabet

$1,095.61

-4.91 (-0.45%)

GOOGL

Alphabet Class A

$1,104.31

-6.89 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

RFP

Resolute Forest

$11.70

-0.12 (-1.02%)

13:41
10/23/18
10/23
13:41
10/23/18
13:41
Conference/Events
Resolute Forest to hold a press conference »

Management announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

AEP

American Electric

$73.15

0.01 (0.01%)

13:40
10/23/18
10/23
13:40
10/23/18
13:40
Hot Stocks
American Electric increases quarterly dividend 8.1% to 67c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 11

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.